Blocking of TNF-alpha and IL-1 inhibits leukocyte infiltration at early, but not at late stage of S-aureus-induced arthritis and the concomitant cartilage destruction in rabbits

被引:18
作者
Kimura, M [1 ]
Matsukawa, A [1 ]
Ohkawara, S [1 ]
Takagi, K [1 ]
Yoshinaga, M [1 ]
机构
[1] KUMAMOTO UNIV, SCH MED, DEPT ORTHOPAED SURG, KUMAMOTO 860, JAPAN
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1997年 / 82卷 / 01期
关键词
D O I
10.1006/clin.1996.4276
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
We investigated the involvement of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) in the pathogenesis of heat-killed S. aureus-induced arthritis. TNF-alpha and IL-1 beta peaked at 2 and 24 hr after the injection, respectively, Leukocyte infiltration within 12 hr of the inflammation was significantly inhibited (80%) by coinjection of anti-TNF-alpha mAb and IL-1 receptor antagonist (IL-1Ra) with S. aureus; however, leukocyte infiltration at 24 hr and thereafter was not inhibited by these agents. The loss of proteoglycan in S. aureus-induced arthritis was also unchanged either by anti-TNF-alpha mAb, IL-1Ra, or their combination. These results indicate that direct participation of TNF-alpha and IL-1 in the pathogenesis of S. aureus-induced arthritis may be limited to the early stage of inflammation and blocking of these cytokines did not result in diminishing the severity of inflammation. Thus, therapeutic approaches with the objective to suppress TNF-alpha and IL-1 may not be effective in the clinical treatment of gram-positive bacteria-induced arthritis. (C) 1997 Academic Press, Inc.
引用
收藏
页码:18 / 25
页数:8
相关论文
共 45 条
[1]
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE [J].
ANTIN, JH ;
WEINSTEIN, HJ ;
GUINAN, EC ;
MCCARTHY, P ;
BIERER, BE ;
GILLILAND, DG ;
PARSONS, SK ;
BALLEN, KK ;
RIMM, IJ ;
FALZARANO, G ;
BLOEDOW, DC ;
ABATE, L ;
LEBSACK, M ;
BURAKOFF, SJ ;
FERRARA, JLM .
BLOOD, 1994, 84 (04) :1342-1348
[2]
INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY [J].
AREND, WP .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1445-1451
[3]
INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1995, 38 (02) :151-160
[4]
BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
[5]
PLASMA CYTOKINE AND ENDOTOXIN LEVELS CORRELATE WITH SURVIVAL IN PATIENTS WITH THE SEPSIS SYNDROME [J].
CASEY, LC ;
BALK, RA ;
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) :771-778
[6]
CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434
[7]
DEFORGE LE, 1992, J IMMUNOL, V148, P2133
[8]
DINARELLO CA, 1992, CHEM IMMUNOL, V51, P1
[9]
BLOCKING IL-1 - INTERLEUKIN-1 RECEPTOR ANTAGONIST INVIVO AND INVITRO [J].
DINARELLO, CA ;
THOMPSON, RC .
IMMUNOLOGY TODAY, 1991, 12 (11) :404-410
[10]
ROLE OF TNF-ALPHA, IL-1, AND IL-1RA IN THE MEDIATION OF LEUKOCYTE INFILTRATION AND INCREASED VASCULAR-PERMEABILITY IN RABBITS WITH LPS-INDUCED PLEURISY [J].
EDAMITSU, S ;
MATSUKAWA, A ;
OHKAWARA, S ;
TAKAGI, K ;
NARIUCHI, H ;
YOSHINAGA, M .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 75 (01) :68-74